by John Conrad | Apr 6, 2020 | COVID, Member News
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and...
by John Conrad | Apr 3, 2020 | COVID, iBIO News
Following the March 23rd launch of the iBIO COVID-19 PPE Response Fund, we are pleased to announce significant growth in the donation of funds and medical supplies from the life sciences community. Currently the fund has received more than $750,000 in cash...
by John Conrad | Apr 2, 2020 | COVID, iBIO News
iBIO is working to help identify labs and qualified lab workers who are interested in helping the state expand our COVID-19 testing capabilities. Labs will either need to be already CLIA certified or seek CLIA certification from The Illinois Department of Public...
by John Conrad | Mar 31, 2020 | COVID, Member News
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
by John Conrad | Mar 27, 2020 | COVID, iBIO News
On Monday iBIO joined the Illinois Manufacturers Association (IMA) and Governor JB Pritzker to announce the formation of the Essential Equipment Taskforce and iBIO’s COVID-19 PPE Response Fund. Working in partnership with IMA, we will bring additional supplies and...